ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,012Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 2429

$1.31M Total Retail Price of All Prescriptions

Rank: 16 out of 2429

599 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

12% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 18,993 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 1,278 943 1 3
OMEPRAZOLE 1,138 885 2 7
LISINOPRIL 813 680 3 2
SIMVASTATIN 730 551 4 1
FUROSEMIDE 662 551 5 5
WARFARIN SODIUM 553 515 6 11
DONEPEZIL HCL 516 476 7 26
METOPROLOL TARTRATE 489 394 8 9
AMLODIPINE BESYLATE 486 462 9 4
NAMENDA 477 443 10 35
SERTRALINE HCL 408 247 11 23
HYDROCODONE-ACETAMINOPHEN 368 288 S3 12 6
ATORVASTATIN CALCIUM 362 310 13 13
TRAMADOL HCL 352 316 14 17
POLYETHYLENE GLYCOL 3350 344 176 15 56
ALENDRONATE SODIUM 344 251 15 20
METOPROLOL SUCCINATE 312 242 17 12
HYDROCHLOROTHIAZIDE 293 231 18 10
METFORMIN HCL 288 219 19 8
MIRTAZAPINE 282 234 20 63
PRAVASTATIN SODIUM 270 218 21 16
RISPERIDONE 248 132 22 52
TAMSULOSIN HCL 248 204 22 29
ATENOLOL 242 216 24 15
RANITIDINE HCL 241 139 25 24
GABAPENTIN 226 182 26 18
DIVALPROEX SODIUM 223 101 27 78
FORTICAL 217 79 28 214
FENOFIBRATE 196 149 29 48
POTASSIUM CHLORIDE 195 142 30 14
OXYBUTYNIN CHLORIDE ER 193 115 31 79
GLIMEPIRIDE 186 159 32 51
FLUTICASONE PROPIONATE 186 112 32 39
CARVEDILOL 184 150 34 21
QUETIAPINE FUMARATE 183 156 35 77
FLUOXETINE HCL 181 120 36 61
LEVETIRACETAM 179 75 37 91
CITALOPRAM HBR 178 170 38 19
CYMBALTA 161 119 39 58
CLOPIDOGREL 156 143 40 31
LANTUS 153 132 41 45
KLOR-CON M20 151 127 42 60
DIVALPROEX SODIUM ER 148 0 43 111
GLIPIZIDE 148 148 43 47
FENTANYL 147 118 S2 45 59
LAMOTRIGINE 141 52 46 130
LOSARTAN POTASSIUM 141 114 46 22
ALLOPURINOL 131 80 48 33
DIOVAN 131 84 48 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 128 50 27
TRAZODONE HCL 124 74 51 50
CARBIDOPA-LEVODOPA 123 101 52 88
KLOR-CON M10 122 102 53 139
PLAVIX 121 108 54 44
CEPHALEXIN 118 97 55 104
DIGOXIN 117 98 56 43
CRESTOR 113 91 57 25
NYSTOP 106 100 58 228
NITROGLYCERIN PATCH 101 94 59 155
MELOXICAM 97 60 60 40
LEVOFLOXACIN 97 73 60 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 80 62 102
ISOSORBIDE MONONITRATE ER 94 79 62 55
ESCITALOPRAM OXALATE 92 84 64 74
ABILIFY 91 64 65 121
ROPINIROLE HCL 90 90 66 92
BACLOFEN 89 0 67 143
EXELON 87 87 68 132
TRIAMTERENE-HCTZ 87 61 68 53
PANTOPRAZOLE SODIUM 86 56 70 34
TRIAMCINOLONE ACETONIDE 84 51 71 99
PHENYTOIN SODIUM EXTENDED 84 67 71 108
CLONIDINE HCL 81 79 73 68
ZOLPIDEM TARTRATE 81 65 73 28
LOVASTATIN 80 68 75 30
OLANZAPINE 79 63 76 101
SEROQUEL 79 76 76 169
OXCARBAZEPINE 79 36 76 183
ENALAPRIL MALEATE 76 65 79 32
NOVOLOG 73 63 80 127
AMOXICILLIN 73 53 80 128
HYDRALAZINE HCL 71 66 82 81
LANTUS SOLOSTAR 71 47 82 100
VENLAFAXINE HCL ER 70 24 84 98
LOVAZA 70 46 84 134
NOVOLIN R 70 68 84 196
BENAZEPRIL HCL 70 70 84 80
CALCITONIN-SALMON 67 0 88 279
FAMOTIDINE 67 51 88 42
DILANTIN 66 30 90 222
LYRICA 66 66 90 95
TOPIRAMATE 64 11 92 136
VESICARE 63 63 93 158
AZITHROMYCIN 61 51 94 46
LEVOCETIRIZINE DIHYDROCHLORIDE 60 0 95 240
PAROXETINE HCL 59 57 96 67
NABUMETONE 57 27 97 96
PRIMIDONE 55 0 98 233
ADVAIR DISKUS 54 54 99 49
DILTIAZEM 24HR CD 53 46 100 94
NIASPAN 52 27 101 113
DIOVAN HCT 52 32 101 83
HYDROXYZINE HCL 52 13 R 101 178
RAMIPRIL 52 50 101 118
ZETIA 52 52 101 70
IBUPROFEN 51 0 106 57
CIPROFLOXACIN HCL 51 40 106 84
JANUVIA 50 47 108 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.